The 17% decline in hospital-acquired conditions from 2010 to 2014 is the result of a decades long campaign and means lives saved, the avoidance of pain and suffering, and less costly care, said David Blumenthal, MD, MPP, president of The Commonwealth Fund.
The 17% decline in hospital-acquired conditions from 2010 to 2014 is the result of a decades long campaign and means lives saved, the avoidance of pain and suffering, and less costly care, said David Blumenthal, MD, MPP, president of The Commonwealth Fund.
Transcript (slightly modified)
Well the most important thing about the drop in hospital-acquired infections is that it means lives saved and people who haven’t been injured, families that haven’t been affected by the loss of loved ones or the burdens of caring for loved ones who are sick and suffering. It also has the benefit of saving money: avoided safety hazards usually result in less costly care.
Why is it happening now? I think there’s a combination of things. In large trends like this there is almost always multiple factors in play. We’ve had an almost 20-year campaign in the United States to improve safety of care. Perhaps that continuing campaign on behalf of thought leaders, leaders in the safety movement, public policy makers at the federal and state level, perhaps that’s finally penetrated into the work of our major institutions.
We also have had a series of new pay-for-performance programs that have highlighted the opportunity to reduce hospital-acquired, or healthcare-acquired, conditions—some of those are Medicare payments, some are private payments. So we know that payment has increasingly focused on pay-for-performance, including safety improvement.
And then the Affordable Care Act added some momentum when it was passed in 2010 and created penalties for higher-than-expected numbers of hospital-acquired conditions, and also provided technical support in the form of the Partnership for Patients, which is a national alliance of hospitals participating in safety improvement.
So I think there are a lot of things in play. There’s no question this is a very important set of statistics and I’m pretty confident they’re real, because they’re based to some extent on consistent measures developed by the Centers for Disease Control and Prevention, and reported nationally in a consistent way.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
The Federal Trade Commission's (FTC's) vote to ban most employers from issuing and enforcing noncompete clauses could have varying impacts on the health care workforce; federal regulators vastly under-enforced antitrust laws in the hospital sector during the last 2 decades, resulting in increased health costs; the FDA recently found genetic evidence of the H5N1 bird flu virus in pasteurized commercially purchased milk.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More